Low-Grade Serous Carcinoma of the Ovary

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oncology (Williston Park, N.Y.) N.Y.), 2016-07, Vol.30 (7), p.650-652
1. Verfasser:	Grisham, Rachel N
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiogenesis Inhibitors - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bevacizumab - therapeutic use Biomarkers, Tumor - blood CA-125 Antigen - blood Cystadenocarcinoma, Serous - blood Cystadenocarcinoma, Serous - diagnosis Cystadenocarcinoma, Serous - genetics Cystadenocarcinoma, Serous - mortality Cystadenocarcinoma, Serous - therapy Diagnosis Drug resistance Drug therapy Female Genetic aspects Genotypes Health aspects Humans Innovations Membrane Proteins - blood Molecular targeted therapy Mutation Neoplasm Grading Neoplasm Recurrence, Local - blood Neoplasm Recurrence, Local - diagnosis Neoplasm Recurrence, Local - genetics Neoplasm Recurrence, Local - mortality Neoplasm Recurrence, Local - therapy Neoplasm Staging Ovarian cancer Ovarian Neoplasms - blood Ovarian Neoplasms - diagnosis Ovarian Neoplasms - genetics Ovarian Neoplasms - mortality Ovarian Neoplasms - therapy Ovariectomy Proto-Oncogene Proteins B-raf - blood Proto-Oncogene Proteins p21(ras) - blood Survival Analysis Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:
ISSN:	0890-9091